The U.S. government's Countermeasures Injury Compensation Program (CICP) has recently approved four additional claims for compensation related to serious injuries or fatalities linked to COVID-19 vaccines. Among these claims is a death benefit, reflecting the program's ongoing efforts to address the impacts of pandemic-related countermeasures. The latest data, released by the Health Resources and Services Administration (HRSA), indicates that while these claims have been approved, thousands of other applicants continue to face denials for compensation under the program.
Related Articles
Don't miss out on breaking stories and in-depth articles.